Steven Gonias

InstitutionUniversity of California San Diego
Address9500 Gilman Drive #0612
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Regulation of Inflammation by the Fibrinolytic System
    NIH/NHLBI R01HL136395Apr 10, 2017 - Mar 31, 2021
    Role: Principal Investigator
    Schwann Cell NMDA Receptor in PNS Injury
    NIH/NINDS R01NS097590Feb 1, 2017 - Jan 31, 2021
    Role: Principal Investigator
    Targeting the Urokinase Receptor in Glioblastoma Multiforme
    NIH/NCI R01CA169096Mar 1, 2013 - Feb 28, 2018
    Role: Principal Investigator
    Alpha2-macroglobulin in peripheral nerve injury
    NIH/NINDS R01NS054671Jul 1, 2007 - Jun 30, 2013
    Role: Principal Investigator
    Gordon Research Conference 2006 Plasminogen Activation
    NIH/NHLBI R13HL083676Sep 30, 2005 - Aug 31, 2006
    Role: Principal Investigator
    Urokinase Receptor-initiated Cell-signaling
    NIH/NCI R01CA094900Apr 1, 2002 - Aug 31, 2012
    Role: Principal Investigator
    Regulation of Signaling Receptor Activity by LRP-1
    NIH/NHLBI R01HL060551Aug 1, 1999 - Dec 31, 2014
    Role: Principal Investigator
    Regulation of Growth Factor Activity by A2 Macroglobulin
    NIH/NCI R01CA053462Aug 1, 1992 - May 31, 2007
    Role: Principal Investigator
    NIH/NHLBI R01HL045786Sep 30, 1990 - Jul 31, 1994
    Role: Principal Investigator
    NIH/NHLBI K04HL002272Jul 1, 1989 - Jun 30, 1994
    Role: Principal Investigator
    University of Virginia Cancer Center Support Grant
    NIH P30CA044579Jul 1, 1987 - Jan 31, 2022
    Role: Co-Investigator
    Medical Scientist Training Program
    NIH/NIGMS T32GM007267Jul 1, 1977 - Jun 30, 2020
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Gonias SL. Mechanisms by Which LRP1 (Low-Density Lipoprotein Receptor-Related Protein-1) Maintains Arterial Integrity. Arterioscler Thromb Vasc Biol. 2018 Nov; 38(11):2548-2549. PMID: 30354248.
      View in: PubMed
    2. Gonias SL, Banki MA, Gilder AS, Azmoon P, Campana WM, Mantuano E. PAI1 blocks effects of tissue-type plasminogen activator on cell-signaling and physiology mediated by the NMDA receptor. J Cell Sci. 2018 Jun 21. PMID: 29930084.
      View in: PubMed
    3. Poplawski G, Ishikawa T, Brifault C, Lee-Kubli C, Regestam R, Henry KW, Shiga Y, Kwon H, Ohtori S, Gonias SL, Campana WM. Schwann cells regulate sensory neuron gene expression before and after peripheral nerve injury. Glia. 2018 Mar 09. PMID: 29520865.
      View in: PubMed
    4. Gilder AS, Natali L, Van Dyk DM, Zalfa C, Banki MA, Pizzo DP, Wang H, Klemke RL, Mantuano E, Gonias SL. The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres. Sci Rep. 2018 Feb 14; 8(1):2982. PMID: 29445239.
      View in: PubMed
    5. Gonias SL, Karimi-Mostowfi N, Murray SS, Mantuano E, Gilder AS. Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival. PLoS One. 2017; 12(10):e0186649. PMID: 29088295.
      View in: PubMed
    6. Brifault C, Gilder AS, Laudati E, Banki M, Gonias SL. Shedding of membrane-associated LDL receptor-related protein-1 from microglia amplifies and sustains neuroinflammation. J Biol Chem. 2017 11 10; 292(45):18699-18712. PMID: 28972143.
      View in: PubMed
    7. Mantuano E, Azmoon P, Brifault C, Banki MA, Gilder AS, Campana WM, Gonias SL. Tissue-type plasminogen activator regulates macrophage activation and innate immunity. Blood. 2017 09 14; 130(11):1364-1374. PMID: 28684538.
      View in: PubMed
    8. Campana WM, Mantuano E, Azmoon P, Henry K, Banki MA, Kim JH, Pizzo DP, Gonias SL. Ionotropic glutamate receptors activate cell signaling in response to glutamate in Schwann cells. FASEB J. 2017 04; 31(4):1744-1755. PMID: 28073836.
      View in: PubMed
    9. Gilder AS, Wang L, Natali L, Karimi-Mostowfi N, Brifault C, Gonias SL. Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion. PLoS One. 2016; 11(12):e0168418. PMID: 27977780.
      View in: PubMed
    10. Flütsch A, Henry K, Mantuano E, Lam MS, Shibayama M, Takahashi K, Gonias SL, Campana WM. Evidence that LDL receptor-related protein 1 acts as an early injury detection receptor and activates c-Jun in Schwann cells. Neuroreport. 2016 12 14; 27(18):1305-1311. PMID: 27824728.
      View in: PubMed
    11. Hau AM, Leivo MZ, Gilder AS, Hu JJ, Gonias SL, Hansel DE. mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer. Cell Signal. 2017 01; 29:96-106. PMID: 27777073.
      View in: PubMed
    12. Laudati E, Gilder AS, Lam MS, Misasi R, Sorice M, Gonias SL, Mantuano E. The activities of LDL Receptor-related Protein-1 (LRP1) compartmentalize into distinct plasma membrane microdomains. Mol Cell Neurosci. 2016 10; 76:42-51. PMID: 27565578.
      View in: PubMed
    13. Mantuano E, Brifault C, Lam MS, Azmoon P, Gilder AS, Gonias SL. LDL receptor-related protein-1 regulates NF?B and microRNA-155 in macrophages to control the inflammatory response. Proc Natl Acad Sci U S A. 2016 Feb 02; 113(5):1369-74. PMID: 26787872; PMCID: PMC4747752.
    14. Jones KA, Gilder AS, Lam MS, Du N, Banki MA, Merati A, Pizzo DP, VandenBerg SR, Gonias SL. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature. Neuro Oncol. 2016 05; 18(5):667-78. PMID: 26420897; PMCID: PMC4827039 [Available on 05/01/17].
    15. Mantuano E, Lam MS, Shibayama M, Campana WM, Gonias SL. The NMDA receptor functions independently and as an LRP1 co-receptor to promote Schwann cell survival and migration. J Cell Sci. 2015 Sep 15; 128(18):3478-88. PMID: 26272917; PMCID: PMC4594737.
    16. Gonias SL, Hu J. Urokinase receptor and resistance to targeted anticancer agents. Front Pharmacol. 2015; 6:154. PMID: 26283964; PMCID: PMC4515545.
    17. Gilder AS, Jones KA, Hu J, Wang L, Chen CC, Carter BS, Gonias SL. Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion. J Biol Chem. 2015 Jun 12; 290(24):14798-809. PMID: 25837250; PMCID: PMC4463428.
    18. Wykosky J, Hu J, Gomez GG, Taylor T, Villa GR, Pizzo D, VandenBerg SR, Thorne AH, Chen CC, Mischel PS, Gonias SL, Cavenee WK, Furnari FB. A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma. Cancer Res. 2015 Jan 15; 75(2):394-404. PMID: 25432173; PMCID: PMC4297573.
    19. Hu J, Jo M, Eastman BM, Gilder AS, Bui JD, Gonias SL. uPAR induces expression of transforming growth factor ß and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages. Am J Pathol. 2014 Dec; 184(12):3384-93. PMID: 25310970; PMCID: PMC4258500.
    20. Pasillas MP, Shields S, Reilly R, Strnadel J, Behl C, Park R, Yates JR, Klemke R, Gonias SL, Coppinger JA. Proteomic analysis reveals a role for Bcl2-associated athanogene 3 and major vault protein in resistance to apoptosis in senescent cells by regulating ERK1/2 activation. Mol Cell Proteomics. 2015 Jan; 14(1):1-14. PMID: 24997994; PMCID: PMC4288246.
    21. Demeule M, Beaudet N, Régina A, Besserer-Offroy É, Murza A, Tétreault P, Belleville K, Ché C, Larocque A, Thiot C, Béliveau R, Longpré JM, Marsault É, Leduc R, Lachowicz JE, Gonias SL, Castaigne JP, Sarret P. Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties. J Clin Invest. 2014 Mar; 124(3):1199-213. PMID: 24531547; PMCID: PMC3934173.
    22. Gupta S, Hau AM, Beach JR, Harwalker J, Mantuano E, Gonias SL, Egelhoff TT, Hansel DE. Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion. PLoS One. 2013; 8(11):e81081. PMID: 24312263; PMCID: PMC3842329.
    23. Mantuano E, Lam MS, Gonias SL. LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and myelin-associated glycoprotein. J Biol Chem. 2013 Nov 22; 288(47):34009-18. PMID: 24129569; PMCID: PMC3837140.
    24. Gonias SL, Campana WM. LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system. Am J Pathol. 2014 Jan; 184(1):18-27. PMID: 24128688; PMCID: PMC3873482.
    25. Staudt ND, Jo M, Hu J, Bristow JM, Pizzo DP, Gaultier A, VandenBerg SR, Gonias SL. Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors. Cancer Res. 2013 Jul 01; 73(13):3902-12. PMID: 23633492; PMCID: PMC3702673.
    26. Orita S, Henry K, Mantuano E, Yamauchi K, De Corato A, Ishikawa T, Feltri ML, Wrabetz L, Gaultier A, Pollack M, Ellisman M, Takahashi K, Gonias SL, Campana WM. Schwann cell LRP1 regulates remak bundle ultrastructure and axonal interactions to prevent neuropathic pain. J Neurosci. 2013 Mar 27; 33(13):5590-602. PMID: 23536074; PMCID: PMC3837698.
    27. Fernandez-Castaneda A, Arandjelovic S, Stiles TL, Schlobach RK, Mowen KA, Gonias SL, Gaultier A. Identification of the low density lipoprotein (LDL) receptor-related protein-1 interactome in central nervous system myelin suggests a role in the clearance of necrotic cell debris. J Biol Chem. 2013 Feb 15; 288(7):4538-48. PMID: 23264627; PMCID: PMC3576060.
    28. Stiles TL, Dickendesher TL, Gaultier A, Fernandez-Castaneda A, Mantuano E, Giger RJ, Gonias SL. LDL receptor-related protein-1 is a sialic-acid-independent receptor for myelin-associated glycoprotein that functions in neurite outgrowth inhibition by MAG and CNS myelin. J Cell Sci. 2013 Jan 01; 126(Pt 1):209-20. PMID: 23132925; PMCID: PMC3603516.
    29. Bristow JM, Reno TA, Jo M, Gonias SL, Klemke RL. Dynamic phosphorylation of tyrosine 665 in pseudopodium-enriched atypical kinase 1 (PEAK1) is essential for the regulation of cell migration and focal adhesion turnover. J Biol Chem. 2013 Jan 04; 288(1):123-31. PMID: 23105102; PMCID: PMC3537006.
    30. Eastman BM, Jo M, Webb DL, Takimoto S, Gonias SL. A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen. Cell Signal. 2012 Sep; 24(9):1847-55. PMID: 22617030; PMCID: PMC3383391.
    31. Mantuano E, Henry K, Yamauchi T, Hiramatsu N, Yamauchi K, Orita S, Takahashi K, Lin JH, Gonias SL, Campana WM. The unfolded protein response is a major mechanism by which LRP1 regulates Schwann cell survival after injury. J Neurosci. 2011 Sep 21; 31(38):13376-85. PMID: 21940431; PMCID: PMC3188465.
    32. Hu J, Jo M, Cavenee WK, Furnari F, VandenBerg SR, Gonias SL. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. Proc Natl Acad Sci U S A. 2011 Sep 20; 108(38):15984-9. PMID: 21896743; PMCID: PMC3179096.
    33. Endsley MP, Hu Y, Deng Y, He X, Warejcka DJ, Twining SS, Gonias SL, Zhang M. Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesion. J Biol Chem. 2011 Jul 15; 286(28):24599-607. PMID: 21606500; PMCID: PMC3137035.
    34. Shi Y, Yamauchi T, Gaultier A, Takimoto S, Campana WM, Gonias SL. Regulation of cytokine expression by Schwann cells in response to a2-macroglobulin binding to LRP1. J Neurosci Res. 2011 Apr; 89(4):544-51. PMID: 21290408; PMCID: PMC3560970.
    35. Gonias SL, Gaultier A, Jo M. Regulation of the urokinase receptor (uPAR) by LDL receptor-related protein-1 (LRP1). Curr Pharm Des. 2011; 17(19):1962-9. PMID: 21711236.
      View in: PubMed
    36. Gaultier A, Simon G, Niessen S, Dix M, Takimoto S, Cravatt BF, Gonias SL. LDL receptor-related protein 1 regulates the abundance of diverse cell-signaling proteins in the plasma membrane proteome. J Proteome Res. 2010 Dec 03; 9(12):6689-95. PMID: 20919742; PMCID: PMC2997161.
    37. Jo M, Eastman BM, Webb DL, Stoletov K, Klemke R, Gonias SL. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells. Cancer Res. 2010 Nov 01; 70(21):8948-58. PMID: 20940399; PMCID: PMC2970644.
    38. Gorovoy M, Gaultier A, Campana WM, Firestein GS, Gonias SL. Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages. J Leukoc Biol. 2010 Oct; 88(4):769-78. PMID: 20610799; PMCID: PMC2974427.
    39. Gonias SL. Factor XII bridges coagulation and fibrinolysis again. Blood. 2010 Jun 17; 115(24):4979-80. PMID: 20558624.
      View in: PubMed
    40. Mantuano E, Jo M, Gonias SL, Campana WM. Low density lipoprotein receptor-related protein (LRP1) regulates Rac1 and RhoA reciprocally to control Schwann cell adhesion and migration. J Biol Chem. 2010 May 07; 285(19):14259-66. PMID: 20197276; PMCID: PMC2863187.
    41. Green CE, Liu T, Montel V, Hsiao G, Lester RD, Subramaniam S, Gonias SL, Klemke RL. Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS One. 2009 Aug 21; 4(8):e6713. PMID: 19696929; PMCID: PMC2725301.
    42. Gaultier A, Hollister M, Reynolds I, Hsieh EH, Gonias SL. LRP1 regulates remodeling of the extracellular matrix by fibroblasts. Matrix Biol. 2010 Jan; 29(1):22-30. PMID: 19699300; PMCID: PMC2818094.
    43. Jo M, Lester RD, Montel V, Eastman B, Takimoto S, Gonias SL. Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling. J Biol Chem. 2009 Aug 21; 284(34):22825-33. PMID: 19546228; PMCID: PMC2755690.
    44. Jo M, Takimoto S, Montel V, Gonias SL. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice. Am J Pathol. 2009 Jul; 175(1):190-200. PMID: 19497996; PMCID: PMC2708805.
    45. Shi Y, Mantuano E, Inoue G, Campana WM, Gonias SL. Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci Signal. 2009 Apr 28; 2(68):ra18. PMID: 19401592; PMCID: PMC2696635.
    46. Gaultier A, Wu X, Le Moan N, Takimoto S, Mukandala G, Akassoglou K, Campana WM, Gonias SL. Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis. J Cell Sci. 2009 Apr 15; 122(Pt 8):1155-62. PMID: 19299462; PMCID: PMC2714439.
    47. Mantuano E, Inoue G, Li X, Takahashi K, Gaultier A, Gonias SL, Campana WM. The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor-related protein. J Neurosci. 2008 Nov 05; 28(45):11571-82. PMID: 18987193; PMCID: PMC3837707.
    48. Galliano MF, Toulza E, Jonca N, Gonias SL, Serre G, Guerrin M. Binding of alpha2ML1 to the low density lipoprotein receptor-related protein 1 (LRP1) reveals a new role for LRP1 in the human epidermis. PLoS One. 2008 Jul 23; 3(7):e2729. PMID: 18648652; PMCID: PMC2453322.
    49. Gonias SL. Urokinase: the identity crisis continues. Blood. 2008 Jul 01; 112(1):8. PMID: 18574039.
      View in: PubMed
    50. Mantuano E, Mukandala G, Li X, Campana WM, Gonias SL. Molecular dissection of the human alpha2-macroglobulin subunit reveals domains with antagonistic activities in cell signaling. J Biol Chem. 2008 Jul 18; 283(29):19904-11. PMID: 18499670; PMCID: PMC2459272.
    51. Gaultier A, Arandjelovic S, Niessen S, Overton CD, Linton MF, Fazio S, Campana WM, Cravatt BF, Gonias SL. Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor. Blood. 2008 Jun 01; 111(11):5316-25. PMID: 18369152; PMCID: PMC2396725.
    52. Gaultier A, Arandjelovic S, Li X, Janes J, Dragojlovic N, Zhou GP, Dolkas J, Myers RR, Gonias SL, Campana WM. A shed form of LDL receptor-related protein-1 regulates peripheral nerve injury and neuropathic pain in rodents. J Clin Invest. 2008 Jan; 118(1):161-72. PMID: 18060043; PMCID: PMC2104478.
    53. Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A. 2007 Oct 30; 104(44):17406-11. PMID: 17954920; PMCID: PMC2077269.
    54. Montel V, Gaultier A, Lester RD, Campana WM, Gonias SL. The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development. Cancer Res. 2007 Oct 15; 67(20):9817-24. PMID: 17942912.
      View in: PubMed
    55. Wu X, Li ZF, Brooks R, Komives EA, Torpey JW, Engvall E, Gonias SL, Shelton GD. Autoantibodies in canine masticatory muscle myositis recognize a novel myosin binding protein-C family member. J Immunol. 2007 Oct 01; 179(7):4939-44. PMID: 17878394.
      View in: PubMed
    56. Arandjelovic S, Dragojlovic N, Li X, Myers RR, Campana WM, Gonias SL. A derivative of the plasma protease inhibitor alpha(2)-macroglobulin regulates the response to peripheral nerve injury. J Neurochem. 2007 Oct; 103(2):694-705. PMID: 17725582.
      View in: PubMed
    57. Lester RD, Jo M, Montel V, Takimoto S, Gonias SL. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol. 2007 Jul 30; 178(3):425-36. PMID: 17664334; PMCID: PMC2064849.
    58. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA, Karin M. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature. 2007 Apr 05; 446(7136):690-4. PMID: 17377533.
      View in: PubMed
    59. Campana WM, Li X, Dragojlovic N, Janes J, Gaultier A, Gonias SL. The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury. J Neurosci. 2006 Oct 25; 26(43):11197-207. PMID: 17065459.
      View in: PubMed
    60. Arandjelovic S, Van Sant CL, Gonias SL. Limited mutations in full-length tetrameric human alpha2-macroglobulin abrogate binding of platelet-derived growth factor-BB and transforming growth factor-beta1. J Biol Chem. 2006 Jun 23; 281(25):17061-8. PMID: 16641085.
      View in: PubMed
    61. Gaultier A, Salicioni AM, Arandjelovic S, Gonias SL. Regulation of the composition of the extracellular matrix by low density lipoprotein receptor-related protein-1: activities based on regulation of mRNA expression. J Biol Chem. 2006 Mar 17; 281(11):7332-40. PMID: 16407289.
      View in: PubMed
    62. Wu L, Gonias SL. The low-density lipoprotein receptor-related protein-1 associates transiently with lipid rafts. J Cell Biochem. 2005 Dec 01; 96(5):1021-33. PMID: 16149055.
      View in: PubMed
    63. Hu K, Yang J, Tanaka S, Gonias SL, Mars WM, Liu Y. Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J Biol Chem. 2006 Jan 27; 281(4):2120-7. PMID: 16303771.
      View in: PubMed
    64. Lester RD, Jo M, Campana WM, Gonias SL. Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem. 2005 Nov 25; 280(47):39273-7. PMID: 16207704.
      View in: PubMed
    65. Li X, Gonias SL, Campana WM. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury. Glia. 2005 Sep; 51(4):254-65. PMID: 15812815.
      View in: PubMed
    66. Mars WM, Jo M, Gonias SL. Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent. Biochem J. 2005 Aug 15; 390(Pt 1):311-5. PMID: 15869463; PMCID: PMC1184584.
    67. Arandjelovic S, Hall BD, Gonias SL. Mutation of lysine 1370 in full-length human alpha2-macroglobulin blocks binding to the low density lipoprotein receptor-related protein-1. Arch Biochem Biophys. 2005 Jun 01; 438(1):29-35. PMID: 15910735.
      View in: PubMed
    68. Mettenburg JM, Arandjelovic S, Gonias SL. A chemically modified preparation of alpha2-macroglobulin binds beta-amyloid peptide with increased affinity and inhibits Abeta cytotoxicity. J Neurochem. 2005 Apr; 93(1):53-62. PMID: 15773905.
      View in: PubMed
    69. Jo M, Thomas KS, Marozkina N, Amin TJ, Silva CM, Parsons SJ, Gonias SL. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. J Biol Chem. 2005 Apr 29; 280(17):17449-57. PMID: 15728176.
      View in: PubMed
    70. Mettenburg JM, Gonias SL. Beta-amyloid peptide binds equivalently to binary and ternary alpha2-macroglobulin-protease complexes. Protein J. 2005 Feb; 24(2):89-93. PMID: 16003950.
      View in: PubMed
    71. Wu L, Arandjelovic S, Gonias SL. Effects of low density lipoprotein receptor-related protein-1 on the expression of platelet-derived growth factor beta-receptor in vitro. J Cell Biochem. 2004 Dec 15; 93(6):1169-77. PMID: 15486970.
      View in: PubMed
    72. Gonias SL, Wu L, Salicioni AM. Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome. Thromb Haemost. 2004 Jun; 91(6):1056-64. PMID: 15175790.
      View in: PubMed
    73. Salicioni AM, Gaultier A, Brownlee C, Cheezum MK, Gonias SL. Low density lipoprotein receptor-related protein-1 promotes beta1 integrin maturation and transport to the cell surface. J Biol Chem. 2004 Mar 12; 279(11):10005-12. PMID: 14699139.
      View in: PubMed
    74. Hope C, Mettenburg J, Gonias SL, DeKosky ST, Kamboh MI, Chu CT. Functional analysis of plasma alpha(2)-macroglobulin from Alzheimer's disease patients with the A2M intronic deletion. Neurobiol Dis. 2003 Dec; 14(3):504-12. PMID: 14678766.
      View in: PubMed
    75. Jo M, Thomas KS, Wu L, Gonias SL. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling. J Biol Chem. 2003 Nov 21; 278(47):46692-8. PMID: 12963722.
      View in: PubMed
    76. Schrecengost JE, LeGallo RD, Boyd JC, Moons KG, Gonias SL, Rose CE, Bruns DE. Comparison of diagnostic accuracies in outpatients and hospitalized patients of D-dimer testing for the evaluation of suspected pulmonary embolism. Clin Chem. 2003 Sep; 49(9):1483-90. PMID: 12928229.
      View in: PubMed
    77. Mathew S, Arandjelovic S, Beyer WF, Gonias SL, Pizzo SV. Characterization of the interaction between alpha2-macroglobulin and fibroblast growth factor-2: the role of hydrophobic interactions. Biochem J. 2003 Aug 15; 374(Pt 1):123-9. PMID: 12755687; PMCID: PMC1223577.
    78. Arandjelovic S, Freed TA, Gonias SL. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta. Biochemistry. 2003 May 27; 42(20):6121-7. PMID: 12755614.
      View in: PubMed
    79. Ma Z, Thomas KS, Webb DJ, Moravec R, Salicioni AM, Mars WM, Gonias SL. Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J Cell Biol. 2002 Dec 23; 159(6):1061-70. PMID: 12499359; PMCID: PMC2173989.
    80. Jo M, Thomas KS, O'Donnell DM, Gonias SL. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J Biol Chem. 2003 Jan 17; 278(3):1642-6. PMID: 12426305.
      View in: PubMed
    81. Strickland DK, Gonias SL, Argraves WS. Diverse roles for the LDL receptor family. Trends Endocrinol Metab. 2002 Mar; 13(2):66-74. PMID: 11854021.
      View in: PubMed
    82. Salicioni AM, Mizelle KS, Loukinova E, Mikhailenko I, Strickland DK, Gonias SL. The low density lipoprotein receptor-related protein mediates fibronectin catabolism and inhibits fibronectin accumulation on cell surfaces. J Biol Chem. 2002 May 03; 277(18):16160-6. PMID: 11867643.
      View in: PubMed
    83. Mettenburg JM, Webb DJ, Gonias SL. Distinct binding sites in the structure of alpha 2-macroglobulin mediate the interaction with beta-amyloid peptide and growth factors. J Biol Chem. 2002 Apr 12; 277(15):13338-45. PMID: 11823454.
      View in: PubMed
    84. Jo M, Thomas KS, Somlyo AV, Somlyo AP, Gonias SL. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J Biol Chem. 2002 Apr 05; 277(14):12479-85. PMID: 11805108.
      View in: PubMed